NL-OMON25865招募中不适用
Sandostatin therapy in sarcoidosis
Erasmus Medical Center, Department of Internal Medicine.0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age above 18 years with obtained written consent
- •2. Have biopsy-proven symptomatic, stable, chronic sarcoidosis for minimal three years.
排除标准
- •1. Corticosteroid use up to three months prior of trial
- •2. Chronic renal failure defined as a GFR below 50%
研究者
相似试验
进行中（未招募）
不适用
Sandostatin therapy in sarcoidosisSarcoidosisEUCTR2013-005376-17-NLErasmus Medical Center
已完成
2 期
Sandostatin therapy in sarcoidosisSarcoidosis10003816NL-OMON40194Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
不适用
STEPS studyNL-OMON20636ErasmusMC50
进行中（未招募）
1 期
Trial for patients with neuro-endocrine tumors with carcinoid syndrome receiving octreotide LAR.The primary objective is to observe the change from baseline in the incidence of diarrhea and flushing in correlation to the serum octreotide level, independently of the dose variations of octreotide LAR.EUCTR2014-003856-30-BECliniques Universitaires Saint Luc50
撤回
4 期
Cardiac Sarcoidosis Response To Steroids TrialCardiac SarcoidosisSarcoidosisNCT01210677Ottawa Heart Institute Research Corporation